Overview
Kenvue Inc., based in the United States, operates predominantly in the consumer health sector. A spin-off from Johnson & Johnson, the company focuses primarily on manufacturing and selling a variety of healthcare products, including over-the-counter medications, beauty items, and wellness solutions. The strategic intent behind Kenvue’s establishment is to tap into the growing global market for personal health products by leveraging its heritage of trust and science-backed innovations derived from its parent company. Key projects for Kenvue involve expanding market reach both domestically and internationally, enhancing its product portfolio through research and development, and increasing consumer engagement through digital transformation. As a newly independent entity, the company aims to assert its market position by concentrating on core areas of consumer healthcare while pursuing sustainable growth.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Kenvue Inc. as of June 29, 2025 is 15,141.00 MM.
- The operating income for Kenvue Inc. as of June 29, 2025 is 2,938.00 MM.
- The net income for Kenvue Inc. as of June 29, 2025 is 1,418.00 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-29 | 15,141.00 | 2,938.00 | 1,418.00 |
| 2025-03-30 | 15,302.00 | 2,900.00 | 1,056.00 |
| 2024-12-29 | 15,455.00 | 2,943.00 | 1,030.00 |
| 2024-09-29 | 15,459.00 | 2,913.00 | 1,064.00 |
| 2024-06-30 | 15,475.00 | 3,023.00 | 1,119.00 |
| 2024-03-31 | 15,486.00 | 2,980.00 | 1,491.00 |
| 2023-12-31 | 15,444.00 | 2,943.00 | 1,664.00 |
| 2023-10-01 | 15,545.00 | 2,841.00 | 1,698.00 |
| 2023-07-02 | 15,419.00 | 2,847.00 | 1,846.00 |
| 2023-04-02 | 15,212.00 | 2,985.00 | 2,005.00 |
| 2023-01-01 | 14,950.00 | 2,894.00 | 2,064.00 |
| 2022-10-02 | 14,916.00 | 2,802.00 | 2,114.00 |
| 2022-01-02 | 15,054.00 | 3,143.00 | 2,078.00 |
| 2021-01-03 | 14,467.00 | 3,046.00 | -879.00 |
Income Statement: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-29 | ||
| 2025-03-30 | 0.55 | 0.56 |
| 2024-12-29 | 0.54 | 0.54 |
| 2024-09-29 | 0.56 | 0.55 |
| 2024-06-30 | 0.58 | 0.57 |
| 2024-03-31 | 0.79 | 0.78 |
| 2023-12-31 | 0.90 | 0.90 |
| 2023-10-01 | 0.95 | 0.94 |
| 2023-07-02 | 1.06 | 1.06 |
| 2023-04-02 | 1.17 | 1.16 |
| 2023-01-01 | 1.20 | 1.20 |
| 2022-10-02 | ||
| 2022-01-02 | 1.21 | 1.21 |
| 2021-01-03 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Kenvue Inc. as of June 29, 2025 is 2,091.00 MM.
- The cash from investing activities for Kenvue Inc. as of June 29, 2025 is -445.00 MM.
- The cash from financing activities for Kenvue Inc. as of June 29, 2025 is -1,607.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-29 | 2,091.00 | -445.00 | -1,607.00 |
| 2025-03-30 | 1,910.00 | -440.00 | -1,549.00 |
| 2024-12-29 | 1,769.00 | -425.00 | -1,565.00 |
| 2024-09-29 | 1,926.00 | -558.00 | -1,361.00 |
| 2024-06-30 | 2,351.00 | -607.00 | -1,925.00 |
| 2024-03-31 | 2,653.00 | -599.00 | -10,241.00 |
| 2023-12-31 | 3,168.00 | -488.00 | -2,527.00 |
| 2023-10-01 | 2,862.00 | -390.00 | -2,207.00 |
| 2023-07-02 | 2,924.00 | -393.00 | -2,116.00 |
| 2023-04-02 | 2,989.00 | -389.00 | 6,015.00 |
| 2023-01-01 | 2,525.00 | -390.00 | -1,583.00 |
| 2022-10-02 | 2,890.00 | -256.00 | -2,420.00 |
| 2022-01-02 | 334.00 | -171.00 | 0.00 |
| 2021-01-03 | 3,397.00 | -83.00 | -3,457.00 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for Kenvue Inc. as of June 29, 2025 is 37.90.
- The p/book for Kenvue Inc. as of June 29, 2025 is 3.98.
- The p/tbv for Kenvue Inc. as of June 29, 2025 is -5.22.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-29 | 37.90 | 3.98 | -5.22 |
| 2025-03-30 | 4.22 | -6.73 | |
| 2024-12-29 | -5.52 | ||
| 2024-09-29 | 39.59 | 4.35 | -5.86 |
| 2024-06-30 | 23.66 | 3.15 | -4.90 |
| 2024-03-31 | 24.68 | 3.77 | -5.14 |
| 2023-12-31 | 23.95 | 3.73 | -5.55 |
| 2023-10-01 | 22.42 | 1.90 | 25.25 |
| 2023-07-02 | |||
| 2023-04-02 | |||
| 2023-01-01 | |||
| 2022-10-02 | |||
| 2022-01-02 | |||
| 2021-01-03 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for Kenvue Inc. as of June 29, 2025 is 0.03.
- The ebit (3y)/ev for Kenvue Inc. as of June 29, 2025 is 0.04.
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-29 | 0.03 | 0.04 |
| 2025-03-30 | 0.03 | 0.04 |
| 2024-12-29 | 0.03 | 0.04 |
| 2024-09-29 | 0.03 | 0.03 |
| 2024-06-30 | 0.05 | 0.06 |
| 2024-03-31 | 0.05 | 0.05 |
| 2023-12-31 | 0.05 | 0.03 |
| 2023-10-01 | 0.05 | 0.02 |
| 2023-07-02 | ||
| 2023-04-02 | ||
| 2023-01-01 | ||
| 2022-10-02 | ||
| 2022-01-02 | ||
| 2021-01-03 |
Management Effectiveness
- The roa for Kenvue Inc. as of June 29, 2025 is 0.04.
- The roe for Kenvue Inc. as of June 29, 2025 is 0.09.
- The roic for Kenvue Inc. as of June 29, 2025 is 0.06.
- The croic for Kenvue Inc. as of June 29, 2025 is -0.01.
- The ocroic for Kenvue Inc. as of June 29, 2025 is 0.10.
| Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
| 2025-06-29 | 0.04 | 0.09 | 0.06 | -0.01 | 0.10 |
| 2025-03-30 | 0.04 | 0.09 | 0.05 | -0.02 | 0.09 |
| 2024-12-29 | 0.04 | 0.10 | 0.05 | -0.00 | 0.10 |
| 2024-09-29 | 0.04 | 0.06 | 0.06 | -0.01 | 0.13 |
| 2024-06-30 | 0.04 | 0.07 | 0.07 | -0.41 | 0.13 |
| 2024-03-31 | 0.06 | 0.08 | 0.09 | 0.01 | 0.16 |
| 2023-12-31 | 0.07 | 0.09 | 0.09 | 0.01 | 0.15 |
| 2023-10-01 | 0.08 | 0.06 | 0.01 | 0.10 | |
| 2023-07-02 | 0.07 | 0.10 | 0.09 | 0.42 | 0.15 |
| 2023-04-02 | 0.10 | 0.10 | 0.02 | ||
| 2023-01-01 | 0.11 | 0.01 | 0.15 | ||
| 2022-10-02 | 0.00 | 0.00 | 0.02 | ||
| 2022-01-02 | |||||
| 2021-01-03 |
Gross Margins
- The gross margin for Kenvue Inc. as of June 29, 2025 is 0.58.
- The net margin for Kenvue Inc. as of June 29, 2025 is 0.07.
- The operating margin for Kenvue Inc. as of June 29, 2025 is 0.18.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
| Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
| 2025-06-29 | 0.58 | 0.07 | 0.18 |
| 2025-03-30 | 0.59 | 0.07 | 0.19 |
| 2024-12-29 | 0.58 | 0.07 | 0.17 |
| 2024-09-29 | 0.58 | 0.07 | 0.18 |
| 2024-06-30 | 0.57 | 0.10 | 0.19 |
| 2024-03-31 | 0.56 | 0.11 | 0.20 |
| 2023-12-31 | 0.56 | 0.11 | 0.20 |
| 2023-10-01 | 0.56 | 0.11 | 0.19 |
| 2023-07-02 | 0.56 | 0.12 | 0.20 |
| 2023-04-02 | 0.14 | 0.20 | |
| 2023-01-01 | 0.55 | 0.14 | 0.19 |
| 2022-10-02 | 0.56 | 0.00 | 0.21 |
| 2022-01-02 | |||
| 2021-01-03 |
Identifiers and Descriptors
| Central Index Key (CIK) | 1944048 |
Industry Groups
| SIC 2844 - Perfumes, Cosmetics, and Other Toilet Preparations |
